In some countries, this medicine may only be approved for veterinary use.
In the US, Brevibloc (esmolol systemic) is a member of the following drug classes: cardioselective beta blockers, group II antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, Intra- or Post-op SVT or Hypertension and Supraventricular Tachycardia.
US matches:
Ingredient matches for Brevibloc
Esmolol
Esmolol is reported as an ingredient of Brevibloc in the following countries:
- Italy
- Portugal
- Switzerland
Esmolol hydrochloride (a derivative of Esmolol) is reported as an ingredient of Brevibloc in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Brazil
- Canada
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Greece
- Ireland
- Israel
- Italy
- Japan
- Luxembourg
- Netherlands
- New Zealand
- Norway
- Poland
- Spain
- Sweden
- Taiwan
- Turkey
- United Kingdom
- United States
International Drug Name Search